Ascendis Pharma A (ASND) Times Interest Earned (2014 - 2026)
Ascendis Pharma A (ASND) reported Times Interest Earned of $0.37 for Q1 2026, up 115.85% on a YoY basis from $0.17 in Q1 2025, and up 1210.0% sequentially from $0.03 in Q4 2025.
Ascendis Pharma A (ASND) Times Interest Earned (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of Times Interest Earned data on file, last reported at $0.37 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 115.85% year-over-year to $0.37; the trailing twelve-month figure through Mar 2026 stood at -$0.01 (down 100.0% YoY), and the FY2025 full-year result was -$0.66, up 76.34% from the prior year.
- Times Interest Earned grew to $0.37 in Q1 2026, from $0.03 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $478.53 in Q4 2022 to a low of -$29.5 million in Q4 2024.
- A 5-year average of -$1.7 million and a median of -$3.5 in 2022 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 169.63% in 2024, while the deepest fall reached 677993512.51% in 2024.
- Tracing ASND's Times Interest Earned over 5 years: stood at $478.53 in 2022, then tumbled by 100.91% to -$4.35 in 2023, then sank by 677993512.51% to -$29.5 million in 2024, then surged by 100.0% to $0.03 in 2025, then jumped by 1210.0% to $0.37 in 2026.
- Business Quant data shows ASND's Times Interest Earned at $0.37 in Q1 2026, $0.03 in Q4 2025, and -$0.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -1.60 |
| Mar 31, 2025 | -2.33 |
| Dec 31, 2024 | -29.46 Mn |
| Sep 30, 2024 | 3.82 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -4.35 |
| Sep 30, 2023 | -5.48 |
| Jun 30, 2023 | -15.09 |
| Mar 31, 2023 | -14.60 |
| Dec 31, 2022 | 478.53 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -15.04 |
| Mar 31, 2022 | -23.71 |
| Dec 31, 2021 | 287.93 |
| Sep 30, 2021 | -110.53 |
| Jun 30, 2021 | -9.69 |